Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin—San Diego County, California, 2009
A single 2g dose of azithromycin effectively treats genitourinary infections caused by susceptible Neisseria gonorrhoea and has been used to treat uncomplicated gonorrhea in persons with cephalosporin allergy. However, azithromycin is not recommended as monotherapy because of concern over the emerge...
Gespeichert in:
| Veröffentlicht in: | JAMA : the journal of the American Medical Association 2011-07, Vol.306 (1), p.33-35 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 35 |
|---|---|
| container_issue | 1 |
| container_start_page | 33 |
| container_title | JAMA : the journal of the American Medical Association |
| container_volume | 306 |
| creator | Katz, Kenneth A Pierce, Elaine F Aiem, Heidi Henderson, Philip Pandori, Mark Wu, Abel Buono, Sean Barry, Pennan M Samuel, Michael Kong, Carol Dixon, Paula Bolan, Gail Weinstock, Hillard S Yee, Eileen L Kirkcaldy, Robert D Khaokham, Christina B |
| description | A single 2g dose of azithromycin effectively treats genitourinary infections caused by susceptible Neisseria gonorrhoea and has been used to treat uncomplicated gonorrhea in persons with cephalosporin allergy. However, azithromycin is not recommended as monotherapy because of concern over the emergence of resistance. Instead, a 1 g dose of azithromycin is recommended as a component of dual therapy for gonorrhea, in conjunction with a cephalosporin. During August-October 2009, five of 55 (9.1%) N. gononhoea isolates obtained from men with symptomatic urethritis tested at San Diego County's main municipal sexually transmitted disease clinic had high azithromycin minimal inhibitory concentrations: three with 8 μg/mL and two with 16 μg/mL. Katz et al summarize the laboratory and epidemiologic findings associated with this reduced susceptibility to azithromycin. A CDC editorial note is included. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_ama_p</sourceid><recordid>TN_cdi_proquest_journals_878527677</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>201181</ama_id><sourcerecordid>2403956931</sourcerecordid><originalsourceid>FETCH-LOGICAL-a130t-95dd40aa9e50c9b692b410fce27483df9aeff8bfff11808781cd2fda7a0fb9ee3</originalsourceid><addsrcrecordid>eNotjk1OwzAUhCMEEqVwAHYW60ay46S2l1X4lSqQKIhl9BI_t67auNjOIqw4BCfkJFgqs5nFfJqZk2zCKi5zXil5mk0oVTIXpSzPs4sQtjSJcTHJzDPaENBbIGvXO-83DgHJh40b8op66FCT1RA6PETb2p2NI4mOLL5S7t1-7Gz_-_2zgp7cWlw7Uruhj-OM1LCzxvnewowUafsyOzOwC3j179Ps_f7urX7Mly8PT_VimQPjNOaq0rqkAAor2ql2roq2ZNR0WKTrXBsFaIxsjTGMSSqFZJ0ujAYB1LQKkU-zm2PvwbvPAUNstm7wfZpsEl0VYi5Egq6PEOyhOXi7Bz82BU2VjP8BlzldxA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>878527677</pqid></control><display><type>article</type><title>Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin—San Diego County, California, 2009</title><source>American Medical Association Journals</source><creator>Katz, Kenneth A ; Pierce, Elaine F ; Aiem, Heidi ; Henderson, Philip ; Pandori, Mark ; Wu, Abel ; Buono, Sean ; Barry, Pennan M ; Samuel, Michael ; Kong, Carol ; Dixon, Paula ; Bolan, Gail ; Weinstock, Hillard S ; Yee, Eileen L ; Kirkcaldy, Robert D ; Khaokham, Christina B</creator><creatorcontrib>Katz, Kenneth A ; Pierce, Elaine F ; Aiem, Heidi ; Henderson, Philip ; Pandori, Mark ; Wu, Abel ; Buono, Sean ; Barry, Pennan M ; Samuel, Michael ; Kong, Carol ; Dixon, Paula ; Bolan, Gail ; Weinstock, Hillard S ; Yee, Eileen L ; Kirkcaldy, Robert D ; Khaokham, Christina B</creatorcontrib><description>A single 2g dose of azithromycin effectively treats genitourinary infections caused by susceptible Neisseria gonorrhoea and has been used to treat uncomplicated gonorrhea in persons with cephalosporin allergy. However, azithromycin is not recommended as monotherapy because of concern over the emergence of resistance. Instead, a 1 g dose of azithromycin is recommended as a component of dual therapy for gonorrhea, in conjunction with a cephalosporin. During August-October 2009, five of 55 (9.1%) N. gononhoea isolates obtained from men with symptomatic urethritis tested at San Diego County's main municipal sexually transmitted disease clinic had high azithromycin minimal inhibitory concentrations: three with 8 μg/mL and two with 16 μg/mL. Katz et al summarize the laboratory and epidemiologic findings associated with this reduced susceptibility to azithromycin. A CDC editorial note is included.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>Chicago: American Medical Association</publisher><subject>Bacterial infections ; Drug therapy ; Gonorrhea ; Mens health</subject><ispartof>JAMA : the journal of the American Medical Association, 2011-07, Vol.306 (1), p.33-35</ispartof><rights>Copyright American Medical Association Jul 6, 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>64,314,780,784</link.rule.ids></links><search><creatorcontrib>Katz, Kenneth A</creatorcontrib><creatorcontrib>Pierce, Elaine F</creatorcontrib><creatorcontrib>Aiem, Heidi</creatorcontrib><creatorcontrib>Henderson, Philip</creatorcontrib><creatorcontrib>Pandori, Mark</creatorcontrib><creatorcontrib>Wu, Abel</creatorcontrib><creatorcontrib>Buono, Sean</creatorcontrib><creatorcontrib>Barry, Pennan M</creatorcontrib><creatorcontrib>Samuel, Michael</creatorcontrib><creatorcontrib>Kong, Carol</creatorcontrib><creatorcontrib>Dixon, Paula</creatorcontrib><creatorcontrib>Bolan, Gail</creatorcontrib><creatorcontrib>Weinstock, Hillard S</creatorcontrib><creatorcontrib>Yee, Eileen L</creatorcontrib><creatorcontrib>Kirkcaldy, Robert D</creatorcontrib><creatorcontrib>Khaokham, Christina B</creatorcontrib><title>Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin—San Diego County, California, 2009</title><title>JAMA : the journal of the American Medical Association</title><description>A single 2g dose of azithromycin effectively treats genitourinary infections caused by susceptible Neisseria gonorrhoea and has been used to treat uncomplicated gonorrhea in persons with cephalosporin allergy. However, azithromycin is not recommended as monotherapy because of concern over the emergence of resistance. Instead, a 1 g dose of azithromycin is recommended as a component of dual therapy for gonorrhea, in conjunction with a cephalosporin. During August-October 2009, five of 55 (9.1%) N. gononhoea isolates obtained from men with symptomatic urethritis tested at San Diego County's main municipal sexually transmitted disease clinic had high azithromycin minimal inhibitory concentrations: three with 8 μg/mL and two with 16 μg/mL. Katz et al summarize the laboratory and epidemiologic findings associated with this reduced susceptibility to azithromycin. A CDC editorial note is included.</description><subject>Bacterial infections</subject><subject>Drug therapy</subject><subject>Gonorrhea</subject><subject>Mens health</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNotjk1OwzAUhCMEEqVwAHYW60ay46S2l1X4lSqQKIhl9BI_t67auNjOIqw4BCfkJFgqs5nFfJqZk2zCKi5zXil5mk0oVTIXpSzPs4sQtjSJcTHJzDPaENBbIGvXO-83DgHJh40b8op66FCT1RA6PETb2p2NI4mOLL5S7t1-7Gz_-_2zgp7cWlw7Uruhj-OM1LCzxvnewowUafsyOzOwC3j179Ps_f7urX7Mly8PT_VimQPjNOaq0rqkAAor2ql2roq2ZNR0WKTrXBsFaIxsjTGMSSqFZJ0ujAYB1LQKkU-zm2PvwbvPAUNstm7wfZpsEl0VYi5Egq6PEOyhOXi7Bz82BU2VjP8BlzldxA</recordid><startdate>20110706</startdate><enddate>20110706</enddate><creator>Katz, Kenneth A</creator><creator>Pierce, Elaine F</creator><creator>Aiem, Heidi</creator><creator>Henderson, Philip</creator><creator>Pandori, Mark</creator><creator>Wu, Abel</creator><creator>Buono, Sean</creator><creator>Barry, Pennan M</creator><creator>Samuel, Michael</creator><creator>Kong, Carol</creator><creator>Dixon, Paula</creator><creator>Bolan, Gail</creator><creator>Weinstock, Hillard S</creator><creator>Yee, Eileen L</creator><creator>Kirkcaldy, Robert D</creator><creator>Khaokham, Christina B</creator><general>American Medical Association</general><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20110706</creationdate><title>Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin—San Diego County, California, 2009</title><author>Katz, Kenneth A ; Pierce, Elaine F ; Aiem, Heidi ; Henderson, Philip ; Pandori, Mark ; Wu, Abel ; Buono, Sean ; Barry, Pennan M ; Samuel, Michael ; Kong, Carol ; Dixon, Paula ; Bolan, Gail ; Weinstock, Hillard S ; Yee, Eileen L ; Kirkcaldy, Robert D ; Khaokham, Christina B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a130t-95dd40aa9e50c9b692b410fce27483df9aeff8bfff11808781cd2fda7a0fb9ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Bacterial infections</topic><topic>Drug therapy</topic><topic>Gonorrhea</topic><topic>Mens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Katz, Kenneth A</creatorcontrib><creatorcontrib>Pierce, Elaine F</creatorcontrib><creatorcontrib>Aiem, Heidi</creatorcontrib><creatorcontrib>Henderson, Philip</creatorcontrib><creatorcontrib>Pandori, Mark</creatorcontrib><creatorcontrib>Wu, Abel</creatorcontrib><creatorcontrib>Buono, Sean</creatorcontrib><creatorcontrib>Barry, Pennan M</creatorcontrib><creatorcontrib>Samuel, Michael</creatorcontrib><creatorcontrib>Kong, Carol</creatorcontrib><creatorcontrib>Dixon, Paula</creatorcontrib><creatorcontrib>Bolan, Gail</creatorcontrib><creatorcontrib>Weinstock, Hillard S</creatorcontrib><creatorcontrib>Yee, Eileen L</creatorcontrib><creatorcontrib>Kirkcaldy, Robert D</creatorcontrib><creatorcontrib>Khaokham, Christina B</creatorcontrib><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katz, Kenneth A</au><au>Pierce, Elaine F</au><au>Aiem, Heidi</au><au>Henderson, Philip</au><au>Pandori, Mark</au><au>Wu, Abel</au><au>Buono, Sean</au><au>Barry, Pennan M</au><au>Samuel, Michael</au><au>Kong, Carol</au><au>Dixon, Paula</au><au>Bolan, Gail</au><au>Weinstock, Hillard S</au><au>Yee, Eileen L</au><au>Kirkcaldy, Robert D</au><au>Khaokham, Christina B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin—San Diego County, California, 2009</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><date>2011-07-06</date><risdate>2011</risdate><volume>306</volume><issue>1</issue><spage>33</spage><epage>35</epage><pages>33-35</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>A single 2g dose of azithromycin effectively treats genitourinary infections caused by susceptible Neisseria gonorrhoea and has been used to treat uncomplicated gonorrhea in persons with cephalosporin allergy. However, azithromycin is not recommended as monotherapy because of concern over the emergence of resistance. Instead, a 1 g dose of azithromycin is recommended as a component of dual therapy for gonorrhea, in conjunction with a cephalosporin. During August-October 2009, five of 55 (9.1%) N. gononhoea isolates obtained from men with symptomatic urethritis tested at San Diego County's main municipal sexually transmitted disease clinic had high azithromycin minimal inhibitory concentrations: three with 8 μg/mL and two with 16 μg/mL. Katz et al summarize the laboratory and epidemiologic findings associated with this reduced susceptibility to azithromycin. A CDC editorial note is included.</abstract><cop>Chicago</cop><pub>American Medical Association</pub><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0098-7484 |
| ispartof | JAMA : the journal of the American Medical Association, 2011-07, Vol.306 (1), p.33-35 |
| issn | 0098-7484 1538-3598 |
| language | eng |
| recordid | cdi_proquest_journals_878527677 |
| source | American Medical Association Journals |
| subjects | Bacterial infections Drug therapy Gonorrhea Mens health |
| title | Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin—San Diego County, California, 2009 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A39%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_ama_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neisseria%20gonorrhoeae%20With%20Reduced%20Susceptibility%20to%20Azithromycin%E2%80%94San%20Diego%20County,%20California,%202009&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Katz,%20Kenneth%20A&rft.date=2011-07-06&rft.volume=306&rft.issue=1&rft.spage=33&rft.epage=35&rft.pages=33-35&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/&rft_dat=%3Cproquest_ama_p%3E2403956931%3C/proquest_ama_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=878527677&rft_id=info:pmid/&rft_ama_id=201181&rfr_iscdi=true |